These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36065552)

  • 1. Successful dupilumab therapy for atopic dermatitis in a patient with X-linked agammaglobulinaemia.
    Fujishima C; Munemoto S; Hioki C; Sasaki H; Yoshida H; Yamamoto T; Kudo H
    Eur J Dermatol; 2022 May; 32(3):416-417. PubMed ID: 36065552
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of atopic dermatitis with dupilumab in the setting of X-linked agammaglobulinemia.
    Fan YH; Lin TL; Sun HL; Pan HH; Ku MS; Lue KH
    J Allergy Clin Immunol Pract; 2022 Nov; 10(11):3032-3034.e1. PubMed ID: 35961615
    [No Abstract]   [Full Text] [Related]  

  • 3.
    Doolan BJ; Yeon J; Baker DA; Whitfeld MJ
    AIDS Res Hum Retroviruses; 2022 Feb; 38(2):76-79. PubMed ID: 34384267
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful use of dupilumab to treat eczema in a child with X-linked agammaglobulinemia.
    Atwal S; Ong PY
    Ann Allergy Asthma Immunol; 2022 Sep; 129(3):384-386. PubMed ID: 35772636
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe atopic dermatitis in a patient with Loeys-Dietz syndrome treated with dupilumab.
    Gkalpakiotis S; Maresova T
    J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):e70-e72. PubMed ID: 35964299
    [No Abstract]   [Full Text] [Related]  

  • 6. Dupilumab alleviates pruritus regardless of skin improvement in adults with atopic dermatitis: A cohort study.
    Chen YW; Chen HH; Huang WN; Hsu CY; Chen YH; Hung WT; Tang KT
    J Am Acad Dermatol; 2024 Jan; 90(1):195-196. PubMed ID: 37751779
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe atopic dermatitis and concurrent severe hidradenitis suppurativa successfully treated with dupilumab.
    Cho MK; Shin JU; Kim DH; Lee HJ
    Clin Exp Dermatol; 2022 Dec; 47(12):2303-2305. PubMed ID: 36006169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous effectiveness of dupilumab in atopic dermatitis and alopecia areata in two patients.
    Ludriksone L; Elsner P; Schliemann S
    J Dtsch Dermatol Ges; 2019 Dec; 17(12):1278-1280. PubMed ID: 31829527
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful dose reduction of dupilumab in atopic dermatitis.
    Ardern-Jones MR; Buchanan EE; Njungu S; O'Driscoll D
    Br J Dermatol; 2023 Apr; 188(5):678-679. PubMed ID: 36662536
    [No Abstract]   [Full Text] [Related]  

  • 10. Dupilumab use in atopic dermatitis and beyond in skin diseases.
    Fourzali K; Golpanian RS; Yosipovitch G
    Immunotherapy; 2020 Dec; 12(17):1221-1235. PubMed ID: 32892674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ulcerative colitis during dupilumab therapy in a patient with atopic dermatitis.
    Seishima M; Sasaki M; Hachiken H; Furukawa T; Yagi N; Sugie S
    J Dermatol; 2023 Dec; 50(12):e420-e421. PubMed ID: 37622193
    [No Abstract]   [Full Text] [Related]  

  • 12. Aarskog-Scott syndrome and atopic dermatitis successfully treated with dupilumab: a casual presentation?
    Calabrese G; Licata G; Buononato D; Gambardella A; De Rosa A; Argenziano G
    Clin Exp Dermatol; 2022 Feb; 47(2):452-453. PubMed ID: 34482546
    [No Abstract]   [Full Text] [Related]  

  • 13. Improvement of alopecia areata with Dupilumab in a patient with severe atopic dermatitis and review the literature.
    Magdaleno-Tapial J; Valenzuela-Oñate C; García-Legaz-Martínez M; Martínez-Domenech Á; Pérez-Ferriols A
    Australas J Dermatol; 2020 May; 61(2):e223-e225. PubMed ID: 31766073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of recurrent exit site and tunnel infections caused by atopic dermatitis with dupilumab: A case report.
    Noda R; Ishibashi Y
    Ther Apher Dial; 2022 Feb; 26(1):255-256. PubMed ID: 34018694
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful response to upadacitinib in the treatment of atopic dermatitis lesions involving sensitive and visible areas resistant to dupilumab treatment.
    Gori N; Ippoliti E; Antonelli F; Peris K; Chiricozzi A
    Clin Exp Dermatol; 2023 Apr; 48(5):558-559. PubMed ID: 36724039
    [No Abstract]   [Full Text] [Related]  

  • 16. Atopic Dermatitis Patient With Hepatitis C Treated With Dupilumab-A Case Report.
    Mota F
    Actas Dermosifiliogr; 2024 Apr; 115(4):T420-T421. PubMed ID: 38325544
    [No Abstract]   [Full Text] [Related]  

  • 17. Atopic Dermatitis Patient With Hepatitis C Treated With Dupilumab-A Case Report.
    Mota F
    Actas Dermosifiliogr; 2024 Apr; 115(4):420-421. PubMed ID: 37290670
    [No Abstract]   [Full Text] [Related]  

  • 18. Dupilumab Improved Alopecia Areata in a Patient with Atopic Dermatitis: A Case Report.
    Uchida H; Kamata M; Watanabe A; Agematsu A; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    Acta Derm Venereol; 2019 Jun; 99(7):675-676. PubMed ID: 30938821
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of Dupilumab for Severe Atopic Dermatitis Co-occurring With Asthma in a Real-World Setting.
    Pose K; Laorden D; Hernández N; Villamañán E; Quirce S; Domínguez-Ortega J
    J Investig Allergol Clin Immunol; 2023 Jun; 33(3):217-219. PubMed ID: 37318773
    [No Abstract]   [Full Text] [Related]  

  • 20. Reported Pregnancy Outcomes in Women With Severe Atopic Dermatitis Treated With Dupilumab: A Systematic Review.
    Akuffo-Addo E; Nicholas MN; Lansang P
    J Cutan Med Surg; 2023; 27(2):177-178. PubMed ID: 36721993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.